-
Marchés
athexgroup.grAthens Exchange GroupLire la suiteTogether for a unified, stronger European capital market.
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Cours MATIF
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Container Freight Futures
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 16 Oct 2023 11:24 CEST |
VIRBAC | VIRBAC: MAR Rapport Hebdomadaire_VIRBAC SA_9 au 13 octobre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 16 Oct 2023 09:57 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 0/2023 | 20103015 Pharmaceuticals | Corporate life |
| 16 Oct 2023 09:57 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 09/2023 | 20103015 Pharmaceuticals | Corporate life |
| 09 Oct 2023 13:18 CEST |
VIRBAC | Virbac will enter the fast-growing poultry vaccines segment in India | 20103015 Pharmaceuticals | Alliances and agreements |
| 09 Oct 2023 13:18 CEST |
VIRBAC | Virbac va pénétrer le segment à forte croissance des vaccins pour volaille en Inde | 20103015 Pharmaceuticals | Alliances and agreements |
| 09 Oct 2023 09:55 CEST |
VIRBAC | VIRBAC: MAR Weekly Report_VIRBAC SA_2 to 6 October 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 09 Oct 2023 09:55 CEST |
VIRBAC | VIRBAC: MAR Rapport Hebdomadaire_VIRBAC SA_2 au 6 octobre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Half-yearly financial report 2023 | 20103015 Pharmaceuticals | - |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Rapport financier semestriel 2023 | 20103015 Pharmaceuticals | - |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Public release of the Half-Year Financial Report at 30 June 2023. | 20103015 Pharmaceuticals | Other subject |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Communiqué de mise à disposition du rapport financier semestriel au 30 juin 2023. | 20103015 Pharmaceuticals | Other subject |
| 02 Oct 2023 10:04 CEST |
VIRBAC | VIRBAC: MAR Weekly Report_VIRBAC SA_25 to 29 September 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 02 Oct 2023 10:04 CEST |
VIRBAC | VIRBAC: MAR Rapport Hebdomadaire_VIRBAC SA_25 au 29 Septembre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 28 Sep 2023 17:45 CEST |
VIRBAC | VIRBAC: current operating income before R&D slightly improving throughout first half of 2023 in percentage of revenue | 20103015 Pharmaceuticals | Sales |
| 28 Sep 2023 17:45 CEST |
VIRBAC | VIRBAC: résultat opérationnel courant avant R&D du premier semestre 2023 en légère amélioration en pourcentage du chiffre d'affaires | 20103015 Pharmaceuticals | Sales |
| 25 Sep 2023 11:53 CEST |
VIRBAC | MAR Weekly Report_VIRBAC SA_18 to 22 September 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 25 Sep 2023 11:53 CEST |
VIRBAC | MAR Rapport Hebdomadaire_VIRBAC SA_18 au 22 septembre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 18 Sep 2023 11:17 CEST |
VIRBAC | MAR Weekly Report_VIRBAC SA_11 to 15 September 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 18 Sep 2023 11:17 CEST |
VIRBAC | MAR Rapport Hebdomadaire_VIRBAC SA_11 au 15 Septembre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 11 Sep 2023 09:43 CEST |
VIRBAC | MAR Report_VIRBAC SA_4 to 8 September 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 11 Sep 2023 09:43 CEST |
VIRBAC | MAR Rapport hebdomadaire_VIRBAC SA_4 AU 8 septembre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 06 Sep 2023 11:40 CEST |
VIRBAC | VIRBAC: MAR Weekly Report_VIRBAC SA_21 to 25 August 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 06 Sep 2023 11:40 CEST |
VIRBAC | VIRBAC: MAR Weekly Report_VIRBAC SA_21 to 25 August 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 05 Sep 2023 15:10 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 08/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 15:10 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 08/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 15:07 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 07/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 15:07 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 07/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 15:01 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 06/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 15:01 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 06/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 14:56 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 05/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 14:56 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 05/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 14:39 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 04/2023 | 20103015 Pharmaceuticals | Corporate life |
| 05 Sep 2023 14:39 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 04/2023 | 20103015 Pharmaceuticals | Corporate life |
| 22 Aug 2023 18:20 CEST |
VIRBAC | Virbac launches a share buyback program | 20103015 Pharmaceuticals | Other subject |
| 22 Aug 2023 18:20 CEST |
VIRBAC | Virbac lance un programme de rachat d’actions propres | 20103015 Pharmaceuticals | Other subject |
| 22 Aug 2023 17:45 CEST |
VIRBAC | VIRBAC - 2023 half-year results: publication postponed to end of September | 20103015 Pharmaceuticals | Other subject |
| 22 Aug 2023 17:45 CEST |
VIRBAC | VIRBAC - Résultats semestriels 2023 : la publication décalée fin septembre | 20103015 Pharmaceuticals | Other subject |
| 18 Jul 2023 17:45 CEST |
VIRBAC | Virbac : Revenue up about 2% during the second quarter and stable at the end of June despite two unfavorable one-off effects throughout the semester | 20103015 Pharmaceuticals | Sales |
| 18 Jul 2023 17:45 CEST |
VIRBAC | Virbac : Chiffre d’affaires en progression d’environ 2% sur le deuxième trimestre et stable à fin juin malgré deux effets ponctuels défavorables sur le semestre | 20103015 Pharmaceuticals | Sales |
| 17 Jul 2023 10:16 CEST |
VIRBAC | Repeat: Virbac reassesses its 2023 growth and Adjusted EBIT1 forecasts | 20103015 Pharmaceuticals | Other subject |
| 17 Jul 2023 10:16 CEST |
VIRBAC | Repeat: Virbac révise ses prévisions de croissance et d’EBIT Ajusté1 2023 | 20103015 Pharmaceuticals | Other subject |
| 11 Jul 2023 10:32 CEST |
VIRBAC | VIRBAC: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2023 | 20103015 Pharmaceuticals | Other subject |
| 03 Jul 2023 18:39 CEST |
VIRBAC | Virbac reassesses its 2023 growth and Adjusted EBIT1 forecasts | 20103015 Pharmaceuticals | - |
| 03 Jul 2023 18:39 CEST |
VIRBAC | Virbac révise ses prévisions de croissance et d’EBIT Ajusté1 2023 | 20103015 Pharmaceuticals | - |
| 29 May 2023 08:00 CEST |
VIRBAC | Virbac: Communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale mixte ordinaire et extraordinaire | 20103015 Pharmaceuticals | - |
| 26 Apr 2023 07:30 CEST |
VIRBAC | Virbac : Public release of Virbac Annual Report at 31 December 2022 (ESEF format) | 20103015 Pharmaceuticals | Income |
| 26 Apr 2023 07:30 CEST |
VIRBAC | Virbac : Communiqué de mise à disposition du Rapport Annuel au format ESEF au 31 décembre 2022 | 20103015 Pharmaceuticals | Income |